Symbol="ENZ"
AssetType="Common Stock"
Name="Enzo Biochem Inc"
Description="Enzo Biochem, Inc., an integrated diagnostic, clinical laboratory, and life science company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company is headquartered in New York, New York."
CIK="316253"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SERVICES-MEDICAL LABORATORIES"
Address="60 EXECUTIVE BLVD, FARMINGDALE, NY, US"
FiscalYearEnd="July"
LatestQuarter="2023-04-30"
MarketCapitalization="65641000"
EBITDA="-40988000"
PERatio="572.95"
PEGRatio="0"
BookValue="0.381"
DividendPerShare="0"
DividendYield="0"
EPS="-0.931"
RevenuePerShareTTM="1.452"
ProfitMargin="-0.642"
OperatingMarginTTM="-0.616"
ReturnOnAssetsTTM="-0.311"
ReturnOnEquityTTM="-112.37"
RevenueTTM="71005000"
GrossProfitTTM="41967000"
DilutedEPSTTM="-0.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.386"
AnalystTargetPrice="5.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.572"
PriceToBookRatio="1.365"
EVToRevenue="0.696"
EVToEBITDA="-3.294"
Beta="0.99"
num_52WeekHigh="2.75"
num_52WeekLow="1"
num_50DayMovingAverage="1.998"
num_200DayMovingAverage="1.889"
SharesOutstanding="49728100"
DividendDate="None"
ExDividendDate="None"
symbol="ENZ"
open="1.36"
high="1.42"
low="1.35"
price="1.41"
volume="195614.00"
latest_trading_day="2023-07-21"
previous_close="1.32"
change="0.09"
change_percent="6.8182%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="619058"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="174"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0002.jpeg"
image_negative_thumbnail_id_2="1136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="694"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_positive_thumbnail_id_2="664"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0044.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
